TOMI Environmental Solutions is set to merge with Carbonium Core, a graphite and rare earth metals producer, in a transaction that will shift ownership to Carbonium's shareholders. The deal is contingent upon securing at least $10 million in financing and gaining approval for a NASDAQ listing. The merger is anticipated to close during the third quarter of 2026, transforming Carbonium into a publicly traded entity focused on nuclear energy infrastructure supply chains.

Under the terms of the Merger Agreement, Carbonium shareholders will receive shares of TOMI’s common stock and a newly created series of non-voting Preferred Stock. Following approval from TOMI’s stockholders as required by Nasdaq Listing Rule 5635(d), the Preferred Stock will convert into common stock. This conversion will result in former Carbonium shareholders owning approximately 90% of the outstanding shares of the combined company.

The transaction is designed to enhance TOMI’s financial condition and drive value for its shareholders by expanding into the high-growth energy sector. The combined company aims to leverage Carbonium's materials across TOMI's existing product lines, including the integration of carbonium graphene into disinfection robotics platforms and the redesign of biosafety drones to utilize carbonium core, graphene, and lithium components.

Strategically, the merger positions the combined entity to pursue a leadership role in the domestic production of nuclear-grade graphite and critical materials. Carbonium Core's strategy relies on domestic feedstock resources and proprietary purification technology licensed from Oak Ridge National Laboratory. The company intends to address supply chain gaps currently dominated by foreign producers, targeting reactor developers, government agencies, and defense contractors.

Management cited the accelerating demand for reliable, carbon-free baseload power, driven by artificial intelligence, hyperscale data centers, and electrification, as a key driver for the merger. "Advanced nuclear power is increasingly recognized as a key solution, and Carbonium Core is positioning itself to become a critical supplier to that ecosystem," said Dr. Halden Shane, Chief Executive Officer of TOMI Environmental Solutions.

Suren Ajjarapu, Chairman and Chief Executive Officer of Carbonium Core, emphasized the importance of domestic production. "Nuclear-grade graphite is irreplaceable in the advanced reactors now being deployed to power AI, data centers, and reindustrialization — yet today it is overwhelmingly sourced abroad," Ajjarapu stated. The combined company plans to advance commercialization efforts and expand intellectual property development to support emerging advanced reactor programs in North America and international markets.

TOMI Environmental Solutions, Inc. reported accelerating adoption of its SteraMist platform on June 23, 2026, as healthcare providers, emergency response agencies, and public health organizations increase spending on biosecurity preparedness. The company attributes the rising commercial demand to a growing number of pathogen outbreaks, including Ebola, measles, and norovirus, which have reinforced the necessity for permanent operational readiness rather than temporary responses. Governments and healthcare systems are investing heavily in preparedness programs to improve response capabilities before future outbreaks occur, creating a significant long-term opportunity for advanced decontamination technologies.

Deployments of SteraMist have expanded internationally, with an established partner broadening usage across emergency medical transport and healthcare facilities to support high-consequence pathogen readiness. In the United States, healthcare systems and federally supported preparedness programs are increasing adoption to strengthen environmental decontamination protocols. The company believes that scalable environmental disinfection solutions are becoming an increasingly important component of operational readiness for critical infrastructure operators and transportation networks.

"We continue to see growing recognition that preparedness cannot begin after an outbreak occurs," said Dr. Halden Shane, CEO of TOMI Environmental Solutions. "Organizations are investing ahead of potential threats, and they are looking for proven technologies that can be deployed rapidly, effectively, and at scale. We believe SteraMist is uniquely positioned to address that need."

Market Drivers and Financial Impact

The global infection prevention and decontamination market is expanding due to increasing awareness of healthcare-associated infections (HAIs), emerging pathogen risks, and stricter regulatory requirements. In the United States alone, HAIs impact approximately one in twenty-five hospital patients and are estimated to contribute tens of billions of dollars annually in healthcare costs. TOMI expects these industry trends to continue supporting commercial momentum throughout 2026 and beyond.

Future Technological Integration

Looking ahead, TOMI sees opportunities to expand deployment through automation, robotics, and emerging autonomous delivery systems. These technologies aim to enhance large-scale decontamination capabilities in hospitals, transportation hubs, public facilities, and emergency response scenarios. The company emphasizes that the ability to disinfect at scale will become increasingly important for protecting large facilities and complex environments quickly and efficiently.